NEWS
LATEST
FULL LIST
-
xolo Partners with Rousselot to Enhance Volumetric Bioprinting with X-Pure GelMA
German 3D printing innovator xolo has entered into a co-branding agreement with Rousselot, a leading collagen and gelatin brand under Darling Ingredients. This collaboration aims to integrate Rousselot’s X-Pure Gelatin Methacrylate (GelMA) solution into xolo’s bioinks for volumetric 3D printers, potentially bridging the gap between research and clinical applications in bioprinting. By combining xolo’s Xolography…
-
Spain’s REIG JOFRE 4D-BIOSKIN Project
REIG JOFRE, a leading pharmaceutical company, announced its participation in the 4D-BIOSKIN project. This initiative aims to validate and scale the production of human skin generated by a 3D bioprinter. Addressing a Critical Global Need According to the World Health Organization (WHO), burns result in approximately 180,000 deaths annually, with countless more individuals suffering from…
-
Xolo Unveils Xube²: Newest Xolography 3D Bioprinter
Berlin-based company Xolo has announced the launch of its latest 3D printer, the Xube², utilizing their proprietary xolography technology. Building on the success of its predecessor, the Xube² promises to set new standards in the field of xolography additive manufacturing, offering unprecedented speed and precision. What is Xolography? Xolography is an innovative 3D printing technology…
-
Further Research on 3D-Bioprinted Mini-Tumors At LACDR
Researchers at the Leiden Academic Centre for Drug Research(LACDR) have continued to test their models to enhance the testing and development of cancer immunotherapies. Using 3D bioprinting technology, they create mini-tumors in a collagen gel that closely mimics human tissue. This method allows them to observe real-time interactions between these mini-tumors and immune cells, providing…
-
3D Bioprinting with Borate Bioactive Glass and Sodium Alginate
A recent study published in Science Direct highlights a new idea of integrating borate bioactive glass (BBG) with sodium alginate (SA) to enhances both printing precision and biocompatibility. This development has potential value for the creation of complex biological structures, including bone and soft tissue implants. Figure taken directly from publication. Sodium alginate, a natural…
-
Egg White-Based Hydrogels as an Alternative Bioink
The study, published in Advanced Functional Materials recently done by the Terasaki Institute for Biomedical Innovation, demonstrates the potential of Egg White Methacryloyl (EWMA) hydrogels as a versatile and highly functional bioink for 3D bioprinting. Why Egg Whites? Egg whites (EW) are rich in proteins like ovalbumin, ovotransferrin, and lysozyme, which provide excellent biocompatibility, bioactivity,…
-
Dr. Josephine Wu’s OPTO-BIOPRINTING Project
Dr. Josephine Wu, a researcher at Trinity College Dublin, is making noise in the field of tissue engineering with her innovative project, OPTO-BIOPRINTING. Supported by an €800,000 Wellcome Early Career Award, Dr. Wu aims to develop a novel approach to creating living tissues. OPTO-BIOPRINTING seeks to overcome current challenges in tissue engineering by leveraging the…
-
Carcinotech’s 3D-Printed Tumor Models: A New Possibility in Cancer Research
Carcinotech’s recent study introduces a potential approach in cancer research through the development of patient-derived, 3D-printed lung cancer models. Their method, showcased at the 2024 European Association for Cancer Research Annual Congress and published in Molecular Oncology, replicates the tumor microenvironment (TME) using cells from patient biopsies, including TME components like cancer stem cells, CAFs,…
-
Brinter’s 3D Bioprinter Set to Board the International Space Station
The intersection of bioprinting and space exploration is reaching a new milestone as Finnish bioprinting firm, Brinter AM Technologies Oy, prepares to launch its Brinter Core 3D bioprinter to the International Space Station (ISS). This project, in collaboration with Redwire Space NV and funded by the European Space Agency (ESA), will see the Brinter Core…
-
CollPlant and Stratasys Initiate Pre-Clinical Study for Regenerative Breast Implants
In a new development for bioprinting, CollPlant Biotechnologies and Stratasys Ltd. have launched a pre-clinical study focused on the viability of 3D-printed, regenerative breast implants. This collaboration marks a significant stride in the $3 billion breast implant market, introducing a novel approach that could redefine both reconstructive and aesthetic procedures. The Innovation Behind the Implants…
Subscribe
Enter your email below to receive updates.
The Business of Biofabrication 